Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-07-08 Sale | 2020-07-09 4:18 pm | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 2,951 | $20 | $59,020 | 209,030 (Direct) | View |
| 2020-06-30 Sale | 2020-07-01 4:39 pm | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 141 | $20 | $2,820 | 211,981 (Direct) | View |
| 2020-05-28 Sale | 2020-06-01 4:15 pm | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 2,232 | $20 | $44,640 | 212,122 (Direct) | View |
| 2020-05-27 Sale | 2020-05-29 4:15 pm | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 448 | $20 | $8,960 | 214,354 (Direct) | View |
| 2020-05-26 Sale | 2020-05-28 4:16 pm | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 412 | $20 | $8,240 | 214,802 (Direct) | View |
| 2020-02-19 Sale | 2020-02-20 4:23 pm | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 6,088 | $20 | $121,760 | 215,214 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-02 Option Award | 2024-01-04 4:15 pm | N/A 2034-01-01 | Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer | 119,000 | $0 | 124,266 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:31 pm | N/A 2033-01-02 | Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-02 6:32 pm | N/A 2032-02-29 | Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer | 117,450 | $0 | 117,450 (Direct) | View |
| 2021-04-12 Option Award | 2021-06-25 5:00 pm | N/A 2031-04-12 | Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer | 500,367 | $0 | 500,367 (Direct) | View |
Ownership | 2021-06-23 8:35 pm | N/A 2031-04-12 | Monte Rosa Therapeutics Inc. | GLUE | Wallace Owen B. Chief Scientific Officer | 0 | $0 | 387,069 (Direct) | View |
| 2020-09-14 Exercise | 2020-09-14 4:19 pm | N/A 2029-01-21 | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 6,350 | $0 | 209,030 (Direct) | View |
| 2020-09-14 Exercise | 2020-09-14 4:19 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 6,350 | $7.84 | 209,030 (Direct) | View |
| 2020-07-08 Exercise | 2020-07-09 4:18 pm | N/A 2029-01-21 | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 2,951 | $0 | 209,030 (Direct) | View |
| 2020-07-08 Exercise | 2020-07-09 4:18 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 2,951 | $7.84 | 209,030 (Direct) | View |
| 2020-06-30 Exercise | 2020-07-01 4:39 pm | N/A 2029-01-21 | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 141 | $0 | 211,981 (Direct) | View |
| 2020-06-30 Exercise | 2020-07-01 4:39 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 141 | $7.84 | 211,981 (Direct) | View |
| 2020-05-28 Exercise | 2020-06-01 4:15 pm | N/A 2029-01-21 | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 2,232 | $0 | 212,122 (Direct) | View |
| 2020-05-28 Exercise | 2020-06-01 4:15 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 2,232 | $7.84 | 212,122 (Direct) | View |
| 2020-05-27 Exercise | 2020-05-29 4:15 pm | N/A 2029-01-21 | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 448 | $0 | 214,354 (Direct) | View |
| 2020-05-27 Exercise | 2020-05-29 4:15 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 448 | $7.84 | 214,354 (Direct) | View |
| 2020-05-26 Exercise | 2020-05-28 4:16 pm | N/A 2029-01-21 | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 412 | $0 | 214,802 (Direct) | View |
| 2020-05-26 Exercise | 2020-05-28 4:16 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 412 | $7.84 | 214,802 (Direct) | View |
| 2020-02-19 Exercise | 2020-02-20 4:23 pm | N/A 2029-01-21 | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 6,088 | $0 | 215,214 (Direct) | View |
| 2020-02-19 Exercise | 2020-02-20 4:23 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 6,088 | $7.84 | 215,214 (Direct) | View |
| 2020-01-23 Option Award | 2020-01-27 4:25 pm | N/A 2030-01-22 | Fulcrum Therapeutics Inc. | FULC | Wallace Owen B. Chief Scientific Officer | 58,900 | $0 | 58,900 (Direct) | View |